Skip to main content
# Title Department Research Member Research Year
151 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Radiotherapy and Nuclear medicine Dr. Dalia Osama Mohamed Ahmed 2021
152 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Pathology Saly Salah Abdelhakeem 2021
153 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
154 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
155 Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
156 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
157 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2021
158 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2021
159 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2021
160 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2021